.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Cantor Fitzgerald
Mallinckrodt
Novartis
US Department of Justice
McKesson
Baxter
Federal Trade Commission
Merck
Cerilliant

Generated: June 23, 2017

DrugPatentWatch Database Preview

DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% Drug Profile

« Back to Dashboard

Which patents cover Dobutamine Hydrochloride In Dextrose 5%, and when can generic versions of Dobutamine Hydrochloride In Dextrose 5% launch?

Dobutamine Hydrochloride In Dextrose 5% is a drug marketed by Hospira and Baxter Hlthcare and is included in three NDAs.

The generic ingredient in DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% is dobutamine hydrochloride. There are fourteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the dobutamine hydrochloride profile page.

Summary for Tradename: DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%

Patents:0
Applicants:2
NDAs:3
Suppliers / Packagers: see list3
Bulk Api Vendors: see list50
Clinical Trials: see list2,439
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%
dobutamine hydrochloride
INJECTABLE;INJECTION020269-001Oct 19, 1993DISCNNoNo► Subscribe► Subscribe
Hospira
DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
dobutamine hydrochloride
INJECTABLE;INJECTION020201-006Jul 7, 1994APRXYesYes► Subscribe► Subscribe
Hospira
DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
dobutamine hydrochloride
INJECTABLE;INJECTION020201-003Oct 19, 1993APRXYesYes► Subscribe► Subscribe
Baxter Hlthcare
DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
dobutamine hydrochloride
INJECTABLE;INJECTION020255-001Oct 19, 1993APRXYesYes► Subscribe► Subscribe
Hospira
DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%
dobutamine hydrochloride
INJECTABLE;INJECTION020269-002Oct 19, 1993DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Baxter
Deloitte
AstraZeneca
Chinese Patent Office
McKesson
McKinsey
US Department of Justice
UBS
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot